11/14
04:05 pm
slno
Soleno Therapeutics Announces Oral Presentations featuring Diazoxide Choline Extended-Release (DCCR) Tablets in Prader-Willi Syndrome at ESPE 2024
Medium
Report
Soleno Therapeutics Announces Oral Presentations featuring Diazoxide Choline Extended-Release (DCCR) Tablets in Prader-Willi Syndrome at ESPE 2024
11/12
06:07 am
slno
Here's Why We're Not At All Concerned With Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn Situation [Yahoo! Finance]
Medium
Report
Here's Why We're Not At All Concerned With Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn Situation [Yahoo! Finance]
11/11
08:10 am
slno
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $70.00 price target on the stock.
Low
Report
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $70.00 price target on the stock.
11/6
04:22 pm
slno
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
Low
Report
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
11/6
04:05 pm
slno
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Low
Report
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
10/28
09:26 am
slno
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at Oppenheimer Holdings Inc. from $65.00 to $73.00. They now have an "outperform" rating on the stock.
Low
Report
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at Oppenheimer Holdings Inc. from $65.00 to $73.00. They now have an "outperform" rating on the stock.
10/28
08:00 am
slno
Soleno Therapeutics to Participate in Upcoming November Investor Conferences
Low
Report
Soleno Therapeutics to Participate in Upcoming November Investor Conferences
10/21
08:00 am
slno
Soleno Therapeutics Announces the Passing of Former Chairman Ernest Mario, Ph.D.
Low
Report
Soleno Therapeutics Announces the Passing of Former Chairman Ernest Mario, Ph.D.
10/15
06:16 pm
slno
Soleno Therapeutics (SLNO): Breakthroughs in Prader-Willi Syndrome Treatment [Yahoo! Finance]
Low
Report
Soleno Therapeutics (SLNO): Breakthroughs in Prader-Willi Syndrome Treatment [Yahoo! Finance]
10/8
06:43 pm
slno
Why Soleno Therapeutics Stock Blasted 9% Higher Today [Yahoo! Finance]
Low
Report
Why Soleno Therapeutics Stock Blasted 9% Higher Today [Yahoo! Finance]
10/8
08:30 am
slno
Soleno Therapeutics Announces Regulatory Update on DCCR (diazoxide choline) Extended-Release Tablets to Treat Prader-Willi Syndrome
Medium
Report
Soleno Therapeutics Announces Regulatory Update on DCCR (diazoxide choline) Extended-Release Tablets to Treat Prader-Willi Syndrome
10/1
01:17 pm
slno
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at Stifel Nicolaus from $59.00 to $74.00. They now have a "buy" rating on the stock.
Low
Report
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at Stifel Nicolaus from $59.00 to $74.00. They now have a "buy" rating on the stock.
9/20
01:29 pm
slno
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $67.00 price target on the stock.
Low
Report
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $67.00 price target on the stock.
9/16
04:05 pm
slno
Soleno Therapeutics to Present at 2024 Cantor Global Healthcare Conference
Low
Report
Soleno Therapeutics to Present at 2024 Cantor Global Healthcare Conference
9/3
08:03 am
slno
Soleno Therapeutics, Inc. (NASDAQ: SLNO) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $70.00 price target on the stock.
Medium
Report
Soleno Therapeutics, Inc. (NASDAQ: SLNO) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $70.00 price target on the stock.
8/27
09:03 pm
slno
Soleno Therapeutics, Inc. (SLNO): One of Oppenheimer's Top Stock Picks For the Next 12 Months [Yahoo! Finance]
Low
Report
Soleno Therapeutics, Inc. (SLNO): One of Oppenheimer's Top Stock Picks For the Next 12 Months [Yahoo! Finance]
8/27
01:57 pm
slno
Soleno Therapeutics: 2 New Catalysts To Bring Forth Change For PWS Patients [Seeking Alpha]
Low
Report
Soleno Therapeutics: 2 New Catalysts To Bring Forth Change For PWS Patients [Seeking Alpha]
8/27
08:00 am
slno
Soleno Therapeutics Announces U.S. FDA Acceptance for Filing and Priority Review of NDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome
Low
Report
Soleno Therapeutics Announces U.S. FDA Acceptance for Filing and Priority Review of NDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome